Aspire Biopharma Holdings, Inc.(ASBP)Stock Analysis

ASBP Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Aspire Biopharma Holdings, Inc. (ASBP), a Healthcare sector company. ASBP is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 33 institutional filers currently hold this stock. Based on the latest XBRL financial filings (Q1 2026), Aspire Biopharma Holdings, Inc. reports quarterly revenue of $28.4K, net income of $-3.2M, free cash flow of $-3.0M. Top institutional holders of ASBP by reported 13-F value include Saba Capital Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., LINDEN ADVISORS, based on the most recent SEC filings. ASBP trades on the Nasdaq exchange and files with the SEC under CIK 1847345. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ASBP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Aspire Biopharma Holdings, Inc. directly from SEC EDGAR.